The effect of lowering blood glucose regarding SGLT2 inhibitor in type 1 diabetes mellitus
Not Applicable
Suspended
- Conditions
- Type 1 diabetes mellitus
- Registration Number
- JPRN-UMIN000036098
- Lead Sponsor
- Tsukuba University Hospital Mito Clinical Education and Training Center Mito Kyodo General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who treat with CSII. 2.Patients who have history of diabetic coma, severe diabetic ketosis or hyperglycemic hyperosmolar symdrome. 3.1.Patients with severe infection, severe injury or perioperative state. 4.1.Patients with severe diabetic complications such as neuropathy, retinopathy and nephropathy. 5.BMI of patients under 17.5 kg/m2. 6.eGFR of patients less than 45 mL/min/1.73m2. 7.Patients with history of ileus. 8.Patients with vulvitis. 9.Pregnant 10.Patients whom researchers rule out as inappropriate subjects.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c, Total daily dose of insulin, BMI
- Secondary Outcome Measures
Name Time Method average blood glucose, standard deviation, mean amplitude of glycemic excursion